Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Nimodipine bulk supplier for pharma manufacturers

Nimodipine 30 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet/ Injection

Available Strengths: 30 mg

Reference Brands: Nimotop (USA)

Category: Neurology

Nimodipine is a Neurology product available as Tablet/ Injection in strengths 30 mg. It corresponds to the reference brand Nimotop (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Nimodipine is a second-generation 1,4-dihydropyridine calcium channel blocker that was initially approved for the management of hypertension. In current clinical practice, it is primarily used to prevent and manage cerebral vasospasm following subarachnoid hemorrhage, a condition that can lead to severe neurological complications. Nimodipine acts by selectively blocking calcium channels in cerebral blood vessels, resulting in vasodilation and improved cerebral blood flow, which helps reduce the risk of ischemic brain injury.

Nimodipine is available in multiple dosage forms, including oral capsules, oral solutions, and intravenous infusions, allowing flexibility in administration based on patient condition and clinical setting. Its ability to cross the blood–brain barrier makes it particularly effective in targeting cerebral vasculature. In addition to its approved indication, nimodipine has been explored for off-label uses in various neurological conditions.

Appropriate administration of nimodipine requires careful consideration of dosing schedules, contraindications, and potential adverse effects such as hypotension, headache, and gastrointestinal disturbances. Continuous monitoring by healthcare professionals is essential to optimize therapeutic outcomes and minimize risks. Proper understanding of nimodipine’s pharmacology supports effective treatment and improved patient outcomes in subarachnoid hemorrhage management.

Nimodipine — third party manufacturing & bulk supply

Nimodipine 30 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Nimodipine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Nimodipine →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions


Nimodipine is used to reduce the risk of neurological damage caused by cerebral vasospasm following subarachnoid hemorrhage.


Nimodipine is a dihydropyridine calcium channel blocker that selectively acts on cerebral blood vessels.


The primary trade name of nimodipine is Nimotop.


Nimodipine is manufactured by multiple pharmaceutical companies worldwide under both branded and generic formulations.


The generic name is nimodipine.


The brand name is Nimotop.


Nimodipine is manufactured in regulated pharmaceutical facilities across the USA, EU, and UK.

Related Products

Valproic Acid

Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL

Form: Tablet / Capsule/ Injection / Oral syrup

Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)

View Details
Ubrogepant

Strength:
50 mg, 100 mg

Form: Tablets

Reference Brands: Ubrelvy (USA/India)

View Details
Tolcapone

Strength:
100 mg

Form: Tablets

Reference Brands: Tasmar (USA/EU)

View Details
Safinamide

Strength:
50 mg ,100 mg

Form: Tablets

Reference Brands: Xadago (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.